BMPR1B (bone morphogenetic protein receptor type 1B) is a serine/threonine kinase receptor that functions as a key regulator of bone and cartilage development through BMP and GDF signaling. Upon ligand binding, BMPR1B forms a heterotetrameric complex with type II receptors, which phosphorylate and activate BMPR1B to initiate SMAD-dependent transcriptional cascades 1. The receptor specifically responds to BMP7/OP-1 and GDF5, positively regulating chondrocyte differentiation and endochondral bone morphogenesis. Beyond skeletal development, BMPR1B has significant reproductive roles: loss-of-function mutations increase ovulation rate and litter size in ewes through altered BMP2/BMP4 and GDF5/GDF9 signaling pathways 12, and BMPR1B variants associate with distinct polycystic ovary syndrome subtypes 3. BMPR1B is implicated in primary ovarian insufficiency etiology 4 and eye development, with pathogenic variants identified in ocular coloboma families 5. Additionally, BMPR1B participates in vascular calcification through eosinophil-derived protein interactions activating Smad1/5/8 signaling 6. Clinically, BMPR1B mutations cause skeletal dysplasias including acromesomelic dysplasia 3 and brachydactyly subtypes. While BMPR1B variants were historically considered for pulmonary arterial hypertension testing, current evidence is disputed with insufficient genetic support 7.